SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 100 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $4,476,000 | +5.7% | 406,929 | -5.8% | 0.01% | +25.0% |
Q1 2017 | $4,234,000 | -8.5% | 432,067 | +0.8% | 0.00% | -20.0% |
Q4 2016 | $4,628,000 | +34.8% | 428,518 | +28.0% | 0.01% | +25.0% |
Q3 2016 | $3,433,000 | +145.9% | 334,880 | +213.3% | 0.00% | +100.0% |
Q2 2016 | $1,396,000 | +199.6% | 106,893 | +152.5% | 0.00% | +100.0% |
Q1 2016 | $466,000 | -13.5% | 42,329 | -30.4% | 0.00% | 0.0% |
Q1 2015 | $539,000 | -13.8% | 60,857 | -14.7% | 0.00% | 0.0% |
Q4 2014 | $625,000 | +49.9% | 71,309 | -22.1% | 0.00% | – |
Q1 2014 | $417,000 | -9.0% | 91,560 | +0.8% | 0.00% | -100.0% |
Q4 2013 | $458,000 | -0.7% | 90,849 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $461,000 | – | 90,849 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |